Physician profile
Michael Tin Sein
NPI 1447484852
$4,496.17
in general payments reported to CMS, 2019-2025
8 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,452 · 2020: $79.80 · 2021: $170 · 2023: $117 · 2024: $1,421 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,283 · Travel and Lodging: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,283.46 |
| Travel and Lodging | $511.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,915.74 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Medtronic, INC. | $1,194.57 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $725.12 | 2019-2024 | Senza |
| Medtronic USA, INC. | $577.43 | 2019 | |
| Abbott Laboratories | $22.59 | 2025 | Eterna |
| Livanova USA, INC. | $21.13 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Forte Bio-Pharma LLC | $20.41 | 2025 | Prolate, Tanlor, Nalocet |
| Nalu Medical, INC. | $19.18 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.